Allient Inc 10-Q for FY2026 Q3

Allient Inc (ALNT)

10-Q 2026-11-04 For: 2026-09-30

Added on November 04, 2026

About this 10-Q

Allient Inc filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Allient reported third-quarter revenue of $164,399 in thousands, up 18%, and net income of $15,325 in thousands, up 137%, for the three months ended September 30, 2026. Bookings increased 64% to $218,057 in thousands. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue: $164.4M; up 18.5% from $138.74M a year earlier
Net income: $15.33M; up 136.6% from net income of $6.48M a year earlier
Diluted EPS: $0.91; up 133.3% from $0.39 a year earlier

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →


Colorado		84-0518115
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

6400 Main Street, Suite 150, Williamsville, New York (Address of principal executive offices)		14221 (Zip Code)

Title of each class		Trading Symbol		Name of each exchange on which registered
Common stock		ALNT		NASDAQ


PART I. FINANCIAL INFORMATION			Page No.

	Item 1.	Financial Statements

		Condensed Consolidated Balance Sheets – Unaudited	1

		Condensed Consolidated Statements of Income and Comprehensive Income – Unaudited	2

		Condensed Consolidated Statements of Stockholders’ Equity – Unaudited	3

		Condensed Consolidated Statements of Cash Flows – Unaudited	4

		Notes to Condensed Consolidated Financial Statements – Unaudited	5

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

	Item 4.	Controls and Procedures	29

PART II. OTHER INFORMATION			29

	Item 1A.	Risk Factors	29

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29

	Item 5.	Other Information	30

	Item 6.	Exhibits	30


		September 30,			December 31,
		2026			2025
Assets
Current assets:
Cash and cash equivalents		$	39,646		$	40,705
Trade receivables, net of provision for credit losses of $951 and $887 at September 30, 2026 and December 31, 2025, respectively			109,633			88,775
Inventories			126,966			109,198
Prepaid expenses and other assets			18,952			14,759
Total current assets			295,197			253,437
Property, plant, and equipment, net			63,191			61,771
Deferred income taxes			10,082			10,509
Intangible assets, net			78,403			88,391
Goodwill			133,137			134,332
Operating lease assets			25,800			21,030
Other long-term assets			8,928			8,125
Total Assets		$	614,738		$	577,595
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable		$	39,676		$	28,433
Accrued liabilities			44,788			40,890
Total current liabilities			84,464			69,323
Long-term debt			173,372			180,389
Deferred income taxes			2,922			3,241
Operating lease liabilities			20,056			16,431
Other long-term liabilities			6,708			6,756
Total liabilities			287,522			276,140
Stockholders’ Equity:
Common stock, no par value, authorized 50,000 shares; 16,989 and 16,936 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively			115,523			113,936
Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding			—			—
Retained earnings			226,273			197,046
Accumulated other comprehensive loss			(14,580)			(9,527)
Total stockholders’ equity			327,216			301,455
Total Liabilities and Stockholders’ Equity		$	614,738		$	577,595


		For the three months ended						For the nine months ended
		September 30,						September 30,
		2026			2025			2026			2025
Revenues		$	164,399		$	138,743		$	457,084		$	411,124
Cost of goods sold			104,214			92,562			297,932			275,835
Gross profit			60,185			46,181			159,152			135,289
Operating costs and expenses:
Selling			7,421			6,217			22,030			18,257
General and administrative			17,078			14,112			48,421			42,364
Engineering and development			10,254			9,687			30,579			29,185
Acquisition and integration-related costs			—			17			—			40
Restructuring and business realignment costs			15			836			1,518			3,457
Amortization of intangible assets			3,117			3,132			9,373			9,350
Total operating costs and expenses			37,885			34,001			111,921			102,653
Operating income			22,300			12,180			47,231			32,636
Other expense, net:
Interest expense			2,494			3,401			7,570			10,588
Other expense, net			110			457			163			1,964
Total other expense, net			2,604			3,858			7,733			12,552
Income before income taxes			19,696			8,322			39,498			20,084
Income tax provision			(4,371)			(1,845)			(8,425)			(4,433)
Net income		$	15,325		$	6,477		$	31,073		$	15,651
Basic earnings per share:
Earnings per share		$	0.91		$	0.39		$	1.85		$	0.94
Basic weighted average common shares			16,800			16,695			16,771			16,658
Diluted earnings per share:
Earnings per share		$	0.91		$	0.39		$	1.84		$	0.94
Diluted weighted average common shares			16,903			16,780			16,886			16,708
Net income		$	15,325		$	6,477		$	31,073		$	15,651
Other comprehensive income (loss):
Foreign currency translation adjustment			(689)			(1,385)			(5,206)			14,121
Change in accumulated (loss) gain on derivatives, net of tax			(18)			(219)			153			(1,254)
Comprehensive income		$	14,618		$	4,873		$	26,020		$	28,518


	Common Stock								Accumulated Other Comprehensive (Loss) Income
(In thousands except per share data)	Shares		Amount			Retained Earnings			Foreign Currency Translation Adjustments			Accumulated income (loss) on derivatives			Pension adjustments			Total Stockholders' Equity
Balances, December 31, 2025	16,936		$	113,936		$	197,046		$	(10,289)		$	503		$	259		$	301,455
Stock transactions under employee benefit stock plans	23			1,512															1,512
Issuance of restricted stock, net of forfeitures	76			(46)															(46)
Stock-based compensation expense				848															848
Shares withheld for payment of employee payroll taxes				(18)															(18)
Comprehensive (loss) income										(2,826)			191						(2,635)
Tax effect of derivative transactions													(45)						(45)
Net income							5,357												5,357
Dividends to stockholders - $0.03							(502)												(502)
Balances, March 31, 2026	17,035		$	116,232		$	201,901		$	(13,115)		$	649		$	259		$	305,926
Stock-based compensation expense				998															998
Shares withheld for payment of employee payroll taxes	(43)			(2,683)															(2,683)
Comprehensive income (loss)										(1,691)			32						(1,659)
Tax effect of derivative transactions													(7)						(7)
Net income							10,391												10,391
Dividends to stockholders - $0.04							(672)												(672)
Balances, June 30, 2026	16,992		$	114,547		$	211,620		$	(14,806)		$	674		$	259		$	312,294
Issuance of restricted stock, net of forfeitures	(3)			—															—
Stock-based compensation expense				983															983
Shares withheld for payment of employee payroll taxes				(7)															(7)
Comprehensive loss										(689)			(22)						(711)
Tax effect of derivative transactions													4						4
Net income							15,325												15,325
Dividends to stockholders - $0.04							(672)												(672)
Balances, September 30, 2026	16,989		$	115,523		$	226,273		$	(15,495)		$	656		$	259		$	327,216


		Three months ended						Nine months ended
		September 30,						September 30,
Target Market		2026			2025			2026			2025
Industrial		$	81,694		$	71,023		$	225,730		$	198,904
Vehicle			27,310			21,584			76,898			71,278
Medical			21,299			21,656			62,604			60,803
Aerospace & Defense			25,493			18,755			70,199			60,753
Distribution and Other			8,603			5,725			21,653			19,386
Total		$	164,399		$	138,743		$	457,084		$	411,124


		September 30,
		2026
Beginning balance	$	134,332
Effect of foreign currency translation		(1,195)
Ending balance	$	133,137


		Weighted Average		September 30, 2026									December 31, 2025
		Amortization		Gross			Accumulated			Net Book			Gross			Accumulated			Net Book
		Period		Amount			Amortization			Value			Amount			Amortization			Value
Customer lists		14.1 years		$	117,111		$	(64,695)		$	52,416		$	117,927		$	(59,006)		$	58,921
Trade name		13.7 years			16,006			(10,084)			5,922			16,105			(9,471)			6,634
Design and technologies		10.5 years			41,845			(21,780)			20,065			42,232			(19,396)			22,836
Total				$	174,962		$	(96,559)		$	78,403		$	176,264		$	(87,873)		$	88,391


		Total
		Estimated
Year ending December 31,		Amortization Expense
Remainder of 2026			3,019
2027			11,892
2028			11,139
2029			9,500
2030			9,346
Thereafter			33,507
Total estimated amortization expense		$	78,403


		Number of
		shares
Outstanding at beginning of period		234,370
Awarded		108,272
Vested		(112,566)
Forfeited		(20,608)
Outstanding at end of period		209,468



		Restructuring
		related accruals

Restructuring liability at December 31, 2025		$	521
Expenses incurred			862
Cash payments			(1,172)
Restructuring liability at March 31, 2026		$	211
Expenses incurred			641
Cash payments			(623)
Restructuring liability at June 30, 2026		$	229
Expenses incurred			15
Cash payments			(244)
Restructuring liability at September 30, 2026		$	-


				Asset Derivatives
				Fair value as of:
Derivatives designated as		Balance Sheet		September 30,			December 31,
hedging instruments		Location		2026			2025
Foreign currency contracts		Prepaid expenses and other assets		$	—		$	7
Interest rate swaps		Prepaid expenses and other assets		$	765		$	619
				$	765		$	626

				Liability Derivatives
				Fair value as of:
Derivatives designated as		Balance Sheet		September 30,			December 31,
hedging instruments		Location		2026			2025
Foreign currency contracts		Accrued liabilities		$	195		$	98
Interest rate products		Accrued liabilities			—			39
				$	195		$	137


		September 30, 2026
		Level 1			Level 2			Level 3
Assets (liabilities)
Deferred compensation plan assets		$	5,657		$	—		$	—
Foreign currency hedge contracts, net			—			(195)			—
Interest rate swaps, net			—			765			—


	Operating Leases		Finance Leases
Remainder of 2026		1,826		213
2027		6,920		873
2028		5,560		895
2029		3,909		917
2030		3,084		940
Thereafter		9,146		6,156
Total undiscounted cash flows	$	30,446	$	9,995
Less: present value discount		(4,594)		(2,238)
Total lease liabilities	$	25,852	$	7,757


		Three months ended						Nine months ended
		September 30,						September 30,
Geography		2026			2025			2026			2025
North America (primarily U.S.)		$	114,786		$	94,838		$	306,053		$	273,463
Europe			44,235			37,470			133,384			118,517
Asia-Pacific			5,378			6,435			17,647			19,144
Total		$	164,399		$	138,743		$	457,084		$	411,124


	September 30,		December 31,
	2026		2025
Parts and raw materials	$	92,566	$	82,875
Work-in-process		15,154		10,602
Finished goods		19,246		15,721
	$	126,966	$	109,198


				September 30,			December 31,
		Useful lives		2026			2025
Land				$	1,790		$	1,798
Building and improvements		5 - 39 years			34,881			30,215
Machinery, equipment, tools and dies		3 - 15 years			124,250			121,774
Construction in progress					2,903			1,636
Furniture, fixtures and other		3 - 10 years			27,073			26,471
					190,897			181,894
Less accumulated depreciation					(127,706)			(120,123)
Property, plant, and equipment, net				$	63,191		$	61,771


		September 30,			December 31,
		2026			2025
Long-term Debt
Revolving Credit Facility, long-term (1)		$	117,962		$	124,962
Note Payable			50,000			50,000
Unamortized debt issuance costs			(1,852)			(2,339)
Finance lease obligations – noncurrent			7,262			7,766
Long-term debt		$	173,372		$	180,389


											Foreign Currency
		Defined Benefit						Tax Effect of			Translation
		Plan Liability			Cash Flow Hedges			Cash Flow Hedges			Adjustment			Total
At June 30, 2026		$	259		$	774		$	(100)		$	(14,806)		$	(13,873)
Unrealized gain (loss) on cash flow hedges			—			(259)			62			—			(197)
Amounts reclassified from AOCI			—			237			(58)			—			179
Foreign currency translation gain			—			—			—			(689)			(689)
At September 30, 2026		$	259		$	752		$	(96)		$	(15,495)		$	(14,580)


		For the three months ended						2026 vs. 2025
		September 30,						Variance
(Dollars in thousands, except per share data)		2026			2025			$			%
Revenues		$	164,399		$	138,743		$	25,656		18	%
Cost of goods sold			104,214			92,562			11,652		13	%
Gross profit			60,185			46,181			14,004		30	%
Gross margin percentage			36.6	%		33.3	%
Operating costs and expenses:
Selling			7,421			6,217			1,204		19	%
General and administrative			17,078			14,112			2,966		21	%
Engineering and development			10,254			9,687			567		6	%
Acquisition and integration-related costs			—			17			(17)		(100)	%
Restructuring and business realignment costs			15			836			(821)		(98)	%
Amortization of intangible assets			3,117			3,132			(15)		—	%
Total operating costs and expenses			37,885			34,001			3,884		11	%
Operating income			22,300			12,180			10,120		83	%
Interest expense			2,494			3,401			(907)		(27)	%
Other expense, net			110			457			(347)		(76)	%
Total other expense			2,604			3,858			(1,254)		(33)	%
Income before income taxes			19,696			8,322			11,374		137	%
Income tax provision			(4,371)			(1,845)			(2,526)		137	%
Net income		$	15,325		$	6,477		$	8,848		137	%

Effective tax rate			22.2	%		22.2	%
Diluted earnings per share		$	0.91		$	0.39		$	0.52		136	%
Bookings		$	218,057		$	133,119		$	84,938		64	%
Backlog		$	351,489		$	230,984		$	120,505		52	%


								2026 vs.
		Nine Months Ended						2025
		September 30,						Variance
(in thousands):		2026			2025			$
Net cash provided by operating activities		$	22,084		$	43,116		$	(21,032)
Net cash used in investing activities			(10,640)			(5,090)			(5,550)
Net cash used in financing activities			(11,899)			(36,997)			25,098
Effect of foreign exchange rates on cash			(604)			2,345			(2,949)
Net increase in cash and cash equivalents		$	(1,059)		$	3,374		$	(4,433)


(a)	Exhibits

	31.1	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	31.2	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

	32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

	101.1 SCH	Inline XBRL Taxonomy Extension Schema Document (filed herewith).

	101.2 CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).

	101.3 DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).

	101.4 LAB	Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).

	101.5 PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).

	104	Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in exhibits 101.) (filed herewith).

DATE:	November 4, 2026	ALLIENT INC.
		By:	/s/ James A. Michaud
		James A. Michaud
		Senior Vice President & Chief Financial Officer


Date: November 4, 2026	/s/ Richard S. Warzala
	Richard S. Warzala
	Chief Executive Officer